CVEvulnerability

CVE-2026-7398

5.5 MEDIUM Published 2026-04-29 Modified 2026-06-17 Official page ↗
Status
Deferred
Published
2026-04-29
Last modified
2026-06-17
Assigner
[email protected]
CVSS 4.0 ([email protected])
5.5 MEDIUM — CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
CVSS 3.1 ([email protected])
7.3 HIGH — CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
CVSS 2.0 ([email protected])
7.5 HIGH — AV:N/AC:L/Au:N/C:P/I:P/A:P
Weaknesses
CWE-22

Description

A weakness has been identified in florensiawidjaja BioinfoMCP up to 7ada7918b9e515604d3c0ae264d3a9af10bf6e54. This vulnerability affects the function Upload of the file bioinfo_mcp_platform/app.py of the component Upload Endpoint. This manipulation of the argument Name causes path traversal. The attack can be initiated remotely. The exploit has been made available to the public and could be used for attacks. Continious delivery with rolling releases is used by this product. Therefore, no version details of affected nor updated releases are available. The project was informed of the problem early through an issue report but has not responded yet.

Related

Weakness · CWE (1)

  • CWE-22 Improper Limitation of a Pathname to a Restricted Directory weakness

References